Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $185K invested in Sonnet BioTherapeutics in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $46K | 17,467 | -1,332 | -7% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $37K | 14,251 | +14,251 | New |
|
|
IC
3
Intersect Capital
San Ramon,
California
| $32K | 12,380 | – | – |
|
4
BlackRock
New York
| $28K | 10,601 | – | – |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $22K | 8,450 | +8,450 | New |
|
6
Bank of America
Charlotte,
North Carolina
| $11K | 4,283 | -46 | -1% |
|
|
SCM
7
Stumpf Capital Management
Scottsdale,
Arizona
| $6K | 2,100 | +2,100 | New |
|
|
TDC
8
Thompson Davis & Co
Richmond,
Virginia
| $3K | 1,000 | – | – |
|
9
UBS Group
Zurich,
Switzerland
| – | – | -6,271 | Closed |
|
|
EVC
10
Eidelman Virant Capital
Saint Louis,
Missouri
| – | – | -979 | Closed |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 2 | – | – |
|